Company intelligence / Profile preview

PeriKard

Ownership: Private
Development stage: Other

Overview

PeriKard developed an advanced toolkit for minimally invasive physician access to the heart’s pericardial space, addressing unmet needs in cardiac procedures such as drainage and ablation for arrhythmias. Following its acquisition by Catheter Precision in February 2025, further development and integration of the technology are ongoing as part of Catheter Precision's product portfolio, with no disclosed clinical results or revenue figures yet.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on PeriKard.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PeriKard.

Explore the full profile